Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Morphic Therapeutic (Nasdaq: MORF) announced that its CEO, Praveen Tipirneni, will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 4:30 PM ET. A live webcast of the presentation will be available on the investor section of the company's website. Morphic is focused on developing oral integrin therapies for serious chronic conditions, including autoimmune and cardiovascular diseases, using its proprietary MInT technology platform. The company collaborates with prominent partners like AbbVie and Janssen.

WALTHAM, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced that Praveen Tipirneni, M.D., president and chief executive officer, will present at the virtual 39^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 4:30 PM ET.

A live webcast of the presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.

About Morphic Therapeutic

Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages the Company’s unique understanding of integrin structure and biology. For more information, visit www.morphictx.com.

Contacts
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com
617.686.1718

Media Contact
Adam Silverstein, Ten Bridge Communications
adam@tenbridgecommunications.com
917.697.9313

FAQ

What is Morphic Therapeutic announcing regarding the J.P. Morgan Healthcare Conference?

Morphic Therapeutic announced that CEO Praveen Tipirneni will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021.

When will Morphic Therapeutic's presentation at the conference take place?

The presentation will take place on January 13, 2021, at 4:30 PM ET.

Where can I watch Morphic Therapeutic's conference presentation?

A live webcast of Morphic Therapeutic's presentation will be available on the investor section of their website.

What does Morphic Therapeutic specialize in?

Morphic Therapeutic develops oral integrin therapies for serious chronic diseases, including autoimmune and cardiovascular conditions.

Who are Morphic Therapeutic's collaborators?

Morphic Therapeutic collaborates with AbbVie, Janssen, and Schrödinger.